Shigeki Ohta

Shigeki Ohta

Auto-generated profile, based on publicly available information

Shigeki Ohta

Cellular Signaling, Institute for Advanced Medical Research, Keio University of School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2022 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
YMYukina Morimoto
Yukina Morimoto
ATAyako Tokumitsu
Ayako Tokumitsu
TSTakefumi Sone
Takefumi Sone
YHYuki Hirota
Yuki Hirota
RTRyota Tamura
Ryota Tamura
SOShigeki Ohta
Shigeki Ohta

11 July 2014 in Neuro-Oncology
Verified
Journal Article
Open access
PDF file
KSKatsuya Saito
Katsuya Saito
YIYukihiko Iizuka
Yukihiko Iizuka
SOShigeki Ohta
Shigeki Ohta
STSatoshi Takahashi
Satoshi Takahashi
KNKenta Nakamura
Kenta Nakamura
MTMasahiro Toda
Masahiro Toda
A cDNA library made from 2 glioma cell lines, U87MG and T98G, was screened by serological identification of antigens by recombinant cDNA expression (SEREX) using serum from a glioblastoma patient. Elongation factor Tu GTP binding domain containing protein 1 (EFTUD1), which is required for ribosome biogenesis, was identified. A cancer microarray database showed overexpression of EFTUD1 in gliomas, suggesting that EFTUD1 is a candidate molecular target for gliomas. EFTUD1 expression in glioma cell lines and glioma tissue was assessed by Western blot, quantitative PCR, and immunohistochemistry. The effect on ribosome biogenesis, cell growth, cell cycle, and induction of apoptosis and autophagy in glioma cells during the downregulation of EFTUD1 was investigated. To reveal the role of autophagy, the autophagy-blocker, chloroquine (CQ), was used in glioma cells downregulating EFTUD1. The effect of combining CQ with EFTUD1 inhibition in glioma cells was analyzed. EFTUD1 expression in glioma cell lines and tissue was higher than in normal brain tissue. Downregulating EFTUD1 induced G1 cell-cycle arrest and apoptosis, leading to reduced glioma cell proliferation. The mechanism underlying this antitumor effect was impaired ribosome biogenesis via EFTUD1 inhibition. Additionally, protective autophagy was induced by glioma cells as an adaptive response to EFTUD1 inhibition. The antitumor effect induced by the combined treatment was significantly higher than that of either EFTUD1 inhibition or CQ alone. These results suggest that EFTUD1 represents a novel therapeutic target and that the combination of EFTUD1 inhibition with autophagy blockade may be effective in the treatment of gliomas.

1 January 2010 in The Proceedings of JSME annual Conference on Robotics and Mechatronics (Robomec)
Verified
Journal Article
Open access
PDF file
TITamon Izawa
Tamon Izawa
KKKazuya Kobayashi
Kazuya Kobayashi
NINobuyuki Ito
Nobuyuki Ito
MOMasahiko Osada
Masahiko Osada
KHKazuo Hongo
Kazuo Hongo
MIMasayuki Inaba
Masayuki Inaba
A Structure of multijoint and variable stiffness realizes various motion of humanoids. Especially, applying for cervical vertebrae of musculoskeletal humanoids affects its cervical part and head. However, almost cervical vertebraes of developed humanoids have basic degree of freedom and number of joints. Furthermore, plenty of tendon-driven cervical spines mount no hardware element to adjust their stiffness. In this paper, we designed a tendon-driven cervical part having three spherical joints and ten tendons. In addition, nonlinear spring elements for adjusting stiffness are inserted in all tendons. Relation between tension force acted on the head and the displacement of head shows changing its stiffness.